-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against SVB Financial Group (SIBV)

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired SVB Financial Group (NASDAQ: SIVB) securities between June 16, 2021 and March 10, 2023, for violations of the Securities Exchange Act of 1934. SVB purports to be “a diversified financial services company, as well as a bank holding company and a financial holding company."

What Now: Similarly situated shareholders may be eligible to participate in the class action against SVB. Shareholders who want to act as lead plaintiff for the class must file their papers by May 8, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: SVB Financial Group (SIVB) Failed to Disclose to Investors That Rising Interest Rates Would Negatively Impact its Business Prospects

According to the complaint, during the class period, defendants failed to disclose: (1) the risks presented by impending rising interest rates; (2) that, in an environment with high interest rates, it would be worse off than banks that did not cater to tech startups and venture capital-backed companies; and (3) that, if its investments were negatively affected by rising interest rates, it was particularly susceptible to a bank run.

On March 8, 2023, the Company announced a stock offering and that it had entered into an agreement with an equity investor to purchase $500 million in a separate private transaction. On this news, the Company's stock lost more than half its value from a closing price of $267.83 per share on March 8, 2023 to $106.04 per share on March 9, 2023. On March 9, 2023, several news outlets speculated on the stock's demise, stating that SVB was impacted by the "Federal Reserve's aggressive campaign to control inflation…" and that "high interest rates spark billions in losses on a $21 million bond portfolio."

On March 10, 2023, trading in SVB’s shares was halted and the California Department of Financial Protection and Innovation took over SVB after the bank tried and failed to find a buyer. SVB’s deposits were transferred to the Federal Deposit Insurance Corporation (“FDIC”). The takeover put about $175 billion in customer deposits under the direct control of the FDIC. The failure of SVB was the largest bank failure since the 2008 financial crisis.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against SVB Financial Group settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:SIVB

Release Summary
SVB Financial Group (SIVB) Failed to Disclose to Investors That Rising Interest Rates Would Negatively Impact its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. For more information, submi...

ARDT Class Action Reminder: Stockholders Who Lost Money Investing in Ardent Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbins LLP is Investigating...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the NuScale Power Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired NuScale Power Corporation (NYSE: SMR) Class A shares between May 13, 2025 and November 6, 2025. NuScale is a nuclear technology company focused on scalable, modular reactors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that...
Back to Newsroom